Cleared Special

Wingman 14C Crossing Catheter (K190393) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K190393 · Reflow Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2019
Decision
79d
Days
Class 2
Risk

K190393 is an FDA 510(k) clearance for the Wingman 14C Crossing Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Reflow Medical, Inc. (San Clemente, US). The FDA issued a Cleared decision on May 9, 2019 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Reflow Medical, Inc. devices

Submission Details

510(k) Number K190393 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2019
Decision Date May 09, 2019
Days to Decision 79 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 125d · This submission: 79d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 318
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K190393.
ASAHI SASUKE
K182844 · Asahi Intecc Co., Ltd. · Jun 2019
Upstream GoBack Crossing Catheter
K182937 · Upstream Peripheral Technologies, Ltd. · May 2019
SOFIA EX Intracranial Support Catheter
K182602 · MicroVention, Inc. · May 2019
Amplatzer Trevisio Intravascular Delivery System
K190581 · Abbott Medical · Apr 2019
Telescope Guide Extension Catheter
K183353 · Medtronic, Inc. · Mar 2019
Ballast 088 Long Sheath
K182918 · Balt USA, LLC · Mar 2019